non-cystic fibrosis bronchiectasis

Insmed Drug for Rare Pulmonary Disorder Meets Phase 2 Goals
Xconomy
Mon, 02/3/20 - 11:56 pm
Insmed
clinical trials
non-cystic fibrosis bronchiectasis
INS1007